“A rose by any other name would smell as sweet” is a popular reference to William Shakespeare’s play Romeo and Juliet, in which Juliet seems to argue that it does not matter that Romeo is from her family’s rival house of Montague.” The reference is often used to imply that the names of things do not affect what they really are.
When observing biological programs within ‘lymph” nodes as well as the folkloric “metastatic” spread of cancer to lymph nodes – we must, in German New Medicine distinguish between what we refer to as “true” lymph tissue versus “branchial or pharyngeal” lymph tissue.
The reason – two different tissue types and therefore two quite differing biological conflicts.
If we do not have the proper understanding of anatomy, embryology (tissue type); we will not ascertain the correct conflict at play and err by barking up the wrong “conflict” tree – ultimately not serving our
The traditional medicine does not acknowledge these distinctions.
“True” lymph tissue (mesodermal) can be found in the groin, abdomen, mediastinum (below the diaphragm) and axilla.
“Branchial or pharyngeal” lymph tissue may be found in the head, neck, face and upper mediastinum (above the diaphragm.)
Branchial or pharyngeal tissue (ectodermal) is derived from the branchial or pharyngeal arches, ducts – in essence, evolutionary “gills.”
Both groups of nodes will demonstrate cell loss or microscopic ulceration during conflict activity with the requisite cellular replenishment (cancer) and swelling during the resolution phase.
The “branchial or pharyngeal” lymph tissue, in a right handed individual responds to a “frontal fear” conflict, in other words fear or danger heading right towards you, heading into danger, heading into a situation where the outcome may have dire consequences. Left handed individuals would respond with a biological conflict of powerlessness, helplessness, no control.
In February of 2009 my mother was misdiagnosed with stage 3-b metastatic adenocarcinoma (alveolar lung cancer.) I was with her when she received the diagnosis as it hit me like a ton if bricks – so much that I had to lie down on the floor as I felt like I would pass out. This was the exact moment-in-time of my conflict-shock.
Her diagnosis for me was perceived by my psyche as danger, heading into a dangerous situation (a frontal fear, a fear of what lie ahead, a fear that confronted me.) Since this was all before I knew about German New Medicine, I spent every hour of every day scouring the internet for help. I was in a state of absolute terror. This was my state of conflict activity. This state went on for 5-6 months.
We connected with a German New Medicine practitioner who reassured us that fear and panic were our worst enemy and that it was important to step back from everything and relax. That was good advice – but I knew from my research that there had to be more than simply relax.
What was my mom’s conflict? How do we go about unearthing it? Was it resolved? How will we know? That was a big one for me because if it wasn’t resolved the tumor would continue to grow (as an adenocarcinoma grows during the conflict active phase.) And, what about tracks? Tracks are reminders within our environment that can reopen the conflict.
It turns out my Mom did not have an adenocarcinoma (a death fright conflict) but rather a bronchial carcinoma (a territorial aggression conflict.) As I started to sob with relief (this was the exact moment-in-time of my danger conflict resolution.)
Back in 2009, I was still very green when it came to German New Medicine but I knew enough to understand what this meant. My mother was in a healing phase! A bronchial carcinoma will only grow after the conflict is resolved. The reason I was sobbing was during the prior five months I was completely unsure as to what was going on. Was the original conflict resolved? Would it keep growing? There were no definitive answers – I was in a constant state of the frontal fear or heading into danger.
I softened as I realized my mom was in a healing phase and the tumor would not get any larger. It was now just a matter of navigating the healing phase. It is not unheard of for a needle biopsy diagnosis to be wrong as multiple embryologic germ or tissue layers are accessed during the procedure.
Once again these nodes as well will demonstrate cell loss or microscopic ulceration during conflict activity with the requisite cellular replenishment and swelling during the resolution phase.
Six 6 weeks later I was at the dentist and happened to feel my neck. I palpated a “lymph node” that was swollen on the left side (mother/child.)
A frontal fear conflict takes to 6-8 weeks to “fill-in” after resolution.
Bingo. It was 6 weeks to the day after my resolution!
Traditional medicine would diagnose this as a non-hodgkin’s lymphoma and begin an aggressive course of surgery, chemotherapy and radiation.
The grading of the lymphoma’s aggressiveness would be dependent upon the timing of the biopsy. If the biopsy was performed early on when the cells were rapidly mitosing (dividing) during the replenishment process, they would appear poorly differentiated and a grim prognosis would result.
If the biopsy was done a bit later as the cellular replenishment slowed down a bit, the diagnosis would be the same – albeit a less aggressive form.
If the biopsy was performed after all cell division (replenishment) was complete, a benign cyst would be now diagnosed!
The following is excerpted and abridged from a wonderfully articulated article by Lauren Sonnenberg which may be fund at lifecoreonline.
As was clearly stated in the outcome of a meta-analysis published in the Journal of Clinical Oncology, Volume 16, 2004, entitled, “The Contribution of Cytotoxic Chemotherapy to 5-year Survival in Adult Malignancies”, chemotherapy has an overall failure rate of 97%. That means it appears to improve 5-year survival in only 3% of cancer cases.
Let’s play “chemo advocate” for a moment and isolate the Hodgkin’s lymphoma results from that study. The highest rate of 5-year survival for chemo users in that study was actually for those with Hodgkin’s lymphoma with a 40.3%. Many might assume that that’s wonderful news and applaud the efficacy of chemo for its specific application to Hodgkin’s disease. That would be an uninformed assumption however. We might ask why there is also a similarly higher survival rate at 37.7%, compared to the overall 3%, for testicular cancer, for example.
“Old brain”-controlled organs and tissues show cell growth, a.k.a. cancer, in the first phase of an active emotional conflict and cell breakdown in the second, or, healing phase. “New brain” – controlled organs and tissues show cell breakdown in the first phase of an active emotional conflict and cell growth, i.e., cancer, in the second, or healing phase. It turns out that the cells involved in the lymph nodes and the testes are “new brain” controlled.
Therefore, by the time a person gets diagnosed with Hodgkin’s lymphoma or testicular cancer, both with “new brain”- controlled cells, they are already in the healing phase. The cancerous growth, i.e., the replenishment of the lost cells, is the healing! On the other hand, in the “old brain” – controlled organs and tissues, chemo actually amplifies the cell growth if applied during the “conflict active” phase. This explains why we see abysmally low survival rates for the majority of the 22 types of cancer in the study, with 9 of the types revealing 0% survival outcomes. It also answers the question as to why it “appears” that chemo works better for some cancers than for others.
In light of the above, since with a 40.3% potential survival rate with chemo, there is still a 59.7% chance that she wouldn’t survive even if given chemo. And, if the evidence that GNM affords us is taken into the account, the reality is that the survival rate with Hodgkin’s lymphoma could potentially be closer to 100% if no chemo were used at all!
This German New Medicine blog is an educational only blog. The information and services contained herein should not be construed as a diagnosis, treatment, prescription or cure for disease. Those seeking treatment for a specific disease should consult with their physician in order to determine the proper, correct and accepted treatment protocol before using anything that is disclosed on this page. Please visit our Legal page for more information.